Takeda inked a multiyear, $170 million-per-program drug discovery partnership with Schrödinger.

GB Sciences will soon start human testing of three cannabis-derived formulations for Parkinson's, chronic pain and cardiovascular diseases.

Science Exchange will offer IndieBio-backed biotech startups access to its outsourced R&D platform.

Neuroscience-focused digital technology company Ixico just nabbed a contract for imaging clinical trial services from Spanish biotech Araclon.

Clinigen has signed exclusive agreements with Mitsubishi Tanabe, Shionogi and Romark to cooperate on expanded access to their medicines.

Veristat finished enrollment for a study sponsored by AOBiome earlier, and that earned it a preferred provider agreement.

Six years after Pfizer's landmark REMOTE trial, Parexel and Sanofi are revisiting the idea of using wearables in clinical trials.

Probably hoping to help turn things around after clinical setbacks, microRNA biotech Regulus tapped the help of CRO Aptuit.